---
title: "Caregiver intentions for childhood and adolescent vaccination after COVID-19 in Lusaka, Zambia"
id: "medrxiv-21-childhood-and-adolescent-immunisation-intentions-post-covid-19-in-lusaka-zambia"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-21-childhood-and-adolescent-immunisation-intentions-post-covid-19-in-lusaka-zambia"
content_type: "clinical_feed_article"
specialty: "Pediatrics"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.21.26363608v1?rss=1"
published_at: "2026-09-23T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Caregiver intentions for childhood and adolescent vaccination after COVID-19 in Lusaka, Zambia
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-21-childhood-and-adolescent-immunisation-intentions-post-covid-19-in-lusaka-zambia
- **Specialty:** [Pediatrics](https://medichelpline.com/clinical-feed/pediatrics.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.21.26363608v1?rss=1)
- **Published At:** 2026-09-23T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This cross-sectional secondary analysis surveyed 277 caregivers in Lusaka, Zambia, between 13 November and 15 December 2023 about perceptions and intentions to vaccinate children aged 0–17 years, with focused questions on adolescents 12–17 years regarding COVID-19 vaccination. - Sample characteristics: median caregiver age 35 years; 66.8% were women. Caregivers included community members and healthcare workers (HCWs). - High reported uptake of **routine childhood vaccinations**: 93.1% of caregivers stated their child had received all recommended routine vaccines. - COVID-19 vaccination uptake differed by caregiver role: HCWs reported higher uptake (68.2% with ≥2 doses) than community caregivers (40.8%). - Among adolescents 12–17 years, 58.0% of caregivers reported their adolescent had received at least one COVID-19 vaccine dose; having a caregiver with ≥2 doses was associated with higher adolescent uptake. - Overall intention to further vaccinate children against COVID-19 was limited: 24.7% of caregivers reported no intent to vaccinate their children further, and intention remained low especially among those whose children were unvaccinated. - Motivations for accepting future novel vaccines included protection from hospitalization and death from diseases such as **malaria**, **TB**, **HIV**, **pneumonia**, **influenza**, and diarrheal diseases (79.1% cited this rationale). - Main reasons for reluctance toward future novel vaccines were fear of potential side effects (45.5%) and insufficient knowledge about benefits and risks (31.8%). - Trusted sources for vaccine information were the **Ministry of Health** (86.6%) and **healthcare professionals** (66.8%). - Authors conclude that while routine vaccine coverage remains high, acceptance of COVID-19 and other novel childhood vaccines is lower and related to caregiver vaccination status; targeted, transparent communication via trusted sources is recommended to address safety concerns and build confidence.
## Clinical Analysis & Structured Key Points
Childhood and adolescent immunisation intentions post-COVID-19 in Lusaka, Zambia | medRxiv Skip to main content Childhood and adolescent immunisation intentions post-COVID-19 in Lusaka, Zambia View ORCID Profile Mwiza Nyasa , View ORCID Profile Anjali Sharma , Andrew D Kerkhoff , Dennis Ngosa , Bertha Shamoya , View ORCID Profile Kombatende Sikombe , Sandra Simbeza , Nelly Zulu , Elvin H Geng , View ORCID Profile Jake M Pry , Noelle Tourneau doi: https://doi.org/10.64898/2026.09.21.26363608 Mwiza Nyasa 1 CIDRZ: Center for Infectious Disease Research in Zambia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Mwiza Nyasa For correspondence: mwizbex{at}gmail.com Anjali Sharma 1 CIDRZ: Center for Infectious Disease Research in Zambia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Anjali Sharma Andrew D Kerkhoff 2 University of California San Francisco; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Dennis Ngosa 1 CIDRZ: Center for Infectious Disease Research in Zambia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Bertha Shamoya 1 CIDRZ: Center for Infectious Disease Research in Zambia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kombatende Sikombe 1 CIDRZ: Center for Infectious Disease Research in Zambia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Kombatende Sikombe Sandra Simbeza 1 CIDRZ: Center for Infectious Disease Research in Zambia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Nelly Zulu 1 CIDRZ: Center for Infectious Disease Research in Zambia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Elvin H Geng 3 Washington University In Saint Louis: Washington University in St Louis; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jake M Pry 4 UC Davis: University of California Davis; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Jake M Pry Noelle Tourneau 5 Zuckerberg San Francisco General Hospital and Trauma Center Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Data/Code Preview PDF Abstract Background: Since the COVID-19 pandemic, parental delays and refusals of well-established, safe, and effective childhood vaccinations have contributed to the resurgence of infectious diseases. This raises concerns that COVID-19 vaccine hesitancy may also extend to novel vaccines for children when introduced in the future. This study examined caregivers’, who included healthcare workers (HCWs), perceptions of novel vaccinations for children ages 0-17 years old and intentions to vaccinate children and adolescents ages 12-17 years against COVID-19. Methods: We conducted a secondary data analysis of a larger cross-sectional survey administered to parents/caregivers of children ages 0-17 years in Lusaka, Zambia, between 13 November and 15 December 2023. Vaccination intention for COVID-19 was specifically focused on caregivers of adolescents ages 12-17 years, following COVID-19 vaccination guidelines during the study. Descriptive statistics were used to explore demographic characteristics, vaccination history, and caregivers’ COVID-19 vaccination status, along with their children’s routine childhood vaccine histories and perceptions of COVID-19 and novel vaccinations. Results: Among 277 caregivers (66.8% women, median age: 35 years), 93.1% reported that their child had received all recommended routine childhood vaccinations. COVID-19 vaccine uptake was higher among HCWs (68.2% with ≥2 doses) than among community members (40.8%) and having ≥2 doses was associated with higher COVID-19 vaccine uptake among their adolescents ages 12-17 years. 58.0% of caregivers indicated that their 12-17 years old adolescents had received at least one COVID-19 vaccine dose. Overall intention to further vaccinate children against COVID-19, especially among those already unvaccinated, remained low, with 24.7% of caregivers reporting no intent to vaccinate their children. Protection from hospitalization and death from malaria, TB, HIV, pneumonia, influenza, and diarrheal diseases were the most cited reason (79.1%) for intention to vaccinate children with novel vaccines for these diseases. The most prominent reasons for reluctance towards future vaccines were the fear of potential side effects (45.5%) and insufficient knowledge about vaccination benefits and risks (31.8%). Caregivers most trusted the Ministry of Health (86.6%) and healthcare professionals (66.8%) as sources of vaccine information. Conclusions: While routine childhood vaccine uptake remained high, acceptance of COVID-19 and future novel vaccines for children was lower and was influenced by caregivers’ own vaccination status. Targeted and transparent communication through trusted sources such as the Ministry of Health and healthcare professionals may be critical for addressing safety concerns and strengthening confidence in novel childhood vaccines. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study received ethical approval from the National Health Research Authority in Lusaka, Zambia (NHRA 000002/17/08/2023), Washington University in St. Louis Institutional Review Board (IRB#: 202308190) and the University of California, and the University of California, San Francisco Institutional Review Board (IRB#: 23-40096). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability A de-identified dataset supporting the conclusions of this article will be made publicly available. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted September 23, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Childhood and adolescent immunisation intentions post-COVID-19 in Lusaka, Zambia Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Childhood and adolescent immunisation intentions post-COVID-19 in Lusaka, Zambia Mwiza Nyasa , Anjali Sharma , Andrew D Kerkhoff , Dennis Ngosa , Bertha Shamoya , Kombatende Sikombe , Sandra Simbeza , Nelly Zulu , Elvin H Geng , Jake M Pry , Noelle Tourneau medRxiv 2026.09.21.26363608; doi: https://doi.org/10.64898/2026.09.21.26363608 Share This Article: Copy Citation Tools Childhood and adolescent immunisation intentions post-COVID-19 in Lusaka, Zambia Mwiza Nyasa , Anjali Sharma , Andrew D Kerkhoff , Dennis Ngosa , Bertha Shamoya , Kombatende Sikombe , Sandra Simbeza , Nelly Zulu , Elvin H Geng , Jake M Pry , Noelle Tourneau medRxiv 2026.09.21.26363608; doi: https://doi.org/10.64898/2026.09.21.26363608 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Public and Global Health Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (905) Anesthesia (336) Cardiovascular Medicine (4839) Dentistry and Oral Medicine (479) Dermatology (419) Emergency Medicine (652) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1635) Epidemiology (15989) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7073) Geriatric Medicine (734) Health Economics (1067) Health Informatics (5075) Health Policy (1438) Health Systems and Quality Improvement (1780) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16317) Intensive Care and Critical Care Medicine (1177) Medical Education (675) Medical Ethics (156) Nephrology (727) Neurology (7321) Nursing (370) Nutrition (1089) Obstetrics and Gynecology (1246) Occupational and Environmental Health (1007) Oncology (3626) Ophthalmology (1058) Orthopedics (398) Otolaryngology (458) Pain Medicine (478) Palliative Medicine (140) Pathology (709) Pediatrics (1807) Pharmacology and Therapeutics (739) Primary Care Research (769) Psychiatry and Clinical Psychology (5929) Public and Global Health (9784) Radiology and Imaging (2439) Rehabilitation Medicine and Physical Therapy (1457) Respiratory Medicine (1251) Rheumatology (644) Sexual and Reproductive Health (775) Sports Medicine (583) Surgery (783) Toxicology (107) Transplantation (306) Urology (295)
## Related Clinical Research

- [Immunogenicity of Sequential Conjugate and Non-Conjugate Pneumococcal Vaccination in Dialysis and](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-immunogenicity-of-sequential-conjugate-and-non-conjugate-pneumococcal.md)
- [FDA approves Moderna’s mRNA flu vaccine mFLUSIVA for adults 50+: what clinicians should know](https://medichelpline.com/clinical-feed/medical-news-today-0-moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-available.md)
- [MMR vaccines: separating measles, mumps, rubella shots — myths and facts](https://medichelpline.com/clinical-feed/medical-news-today-0-should-the-measles-mumps-rubella-vaccines-be-separate-myths-vs-facts.md)
- [E-Bikes and E-Scooters: Addressing the Pediatric Public Health Crisis](https://medichelpline.com/clinical-feed/stat-news-0-opinion-e-bikes-e-scooters-are-a-burgeoning-pediatric-public-health-emergency.md)
- [Monocyte phenotypes associated with peri‑coronary inflammation in people with and without HIV](https://medichelpline.com/clinical-feed/frontiers-in-immunology-15-distinct-monocyte-phenotypes-are-associated-with-peri-coronary-inflammation-in.md)

## Navigation
- [← Back to Pediatrics Feed](https://medichelpline.com/clinical-feed/pediatrics.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.